GLP-1 receptor agonists Archives

Global perspectives
on diabetes

Global perspectives on diabetes

Prof Peter Schwarz, President of the International Diabetes Federation, speaking at the ADA 2026 type 5 diabetes symposium.

ADA 2026: New advances in diabetes care

ADA 2026 Scientific Sessions: Emerging therapies, new disease insights and personalised care

ADA 2026 breakthroughs in diabetes and obesity care, including type 5 diabetes, immunotherapy, stem cells and next-generation treatments

> Read more

overweight old couple, back view of husband and his wife at the park

The link between metabolic syndrome and cognitive decline

The triple burden: how metabolic syndrome and diabetes heighten Alzheimer’s risk

It is not simply the surging rates of diabetes or the quiet march of dementia that are drawing the concern of public health experts—but the potent and often overlooked interplay between the two.

> Read more

Search your topic

Regions

Global perspectives
on diabetes

The link between metabolic syndrome and cognitive decline

IDF links

Search your topic

Regions

Global perspectiveson diabetes

ADA 2026: New advances in diabetes care

The link between metabolic syndrome and cognitive decline

IDF links

Global perspectives
on diabetes